Search
Displaying 1 - 1 of 1 items.
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
AlertHealth professional risk communication | 2021-04-28
Displaying 1 - 1 of 1 items.